PT980241E - Formas de dosagem encapsuladas em gelatina de sertralina em solucao - Google Patents

Formas de dosagem encapsuladas em gelatina de sertralina em solucao

Info

Publication number: PT980241E
Authority: PT; Portugal
Prior art keywords: sercaline; gelatine; solution; dosage forms; forms encapsulated
Prior art date: 1997-07-01

Application number

PT98923021T

Other languages

English (en)

Inventor

William John Curatolo

Ravi Mysore Shanker

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-16

Publication date

2004-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT980241(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-31 Publication of PT980241E publication Critical patent/PT980241E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

PT98923021T 1997-07-01 1998-06-16 Formas de dosagem encapsuladas em gelatina de sertralina em solucao PT980241E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
PT980241E true PT980241E (pt)	2004-03-31

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT98923021T PT980241E (pt)	1997-07-01	1998-06-16	Formas de dosagem encapsuladas em gelatina de sertralina em solucao

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (pt)
JP (1)	JP3585245B2 (pt)
KR (1)	KR100371730B1 (pt)
CN (1)	CN1261792A (pt)
AP (1)	AP945A (pt)
AR (1)	AR015916A1 (pt)
AT (1)	ATE256457T1 (pt)
AU (1)	AU724635B2 (pt)
BG (1)	BG103917A (pt)
BR (1)	BR9809712A (pt)
CA (1)	CA2290973C (pt)
CO (1)	CO4940405A1 (pt)
DE (1)	DE69820608T2 (pt)
DK (1)	DK0980241T3 (pt)
DZ (1)	DZ2544A1 (pt)
EA (1)	EA001905B1 (pt)
ES (1)	ES2210760T3 (pt)
GT (1)	GT199800090A (pt)
HR (1)	HRP980378B1 (pt)
HU (1)	HUP0002250A3 (pt)
ID (1)	ID24673A (pt)
IL (1)	IL133075A0 (pt)
IS (1)	IS5266A (pt)
MA (1)	MA24586A1 (pt)
MY (1)	MY119728A (pt)
NO (1)	NO996492L (pt)
NZ (1)	NZ501252A (pt)
OA (1)	OA11246A (pt)
PA (1)	PA8454001A1 (pt)
PE (1)	PE97299A1 (pt)
PL (1)	PL337807A1 (pt)
PT (1)	PT980241E (pt)
SK (1)	SK282914B6 (pt)
TN (1)	TNSN98123A1 (pt)
TR (1)	TR199903282T2 (pt)
TW (1)	TW382597B (pt)
UA (1)	UA68350C2 (pt)
UY (1)	UY25070A1 (pt)
WO (1)	WO1999001113A1 (pt)
ZA (1)	ZA985709B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EE04868B1 (et) *	1998-10-13	2007-08-15	Pfizer Products Inc.	Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
SI1225881T1 (sl)	1999-09-03	2006-06-30	Apbi Holdings Llc	Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije
AU2001276608A1 (en)	2000-08-30	2002-03-13	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
JP2006507309A (ja) *	2002-10-31	2006-03-02	アルザ・コーポレーシヨン	疎水性薬剤の上昇した生物学的利用性を提供する製剤
WO2016020936A2 (en) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0782445B1 (en) *	1994-09-19	2002-03-13	Dupont Pharmaceuticals Company	Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
EP0768083B1 (en) *	1995-07-17	2003-03-26	Pfizer Inc.	Sertraline for treating post myocardial infarction patients

1998
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Ceased
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
1999
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP3585245B2 (ja)	2004-11-04
EP0980241B1 (en)	2003-12-17
UA68350C2 (en)	2004-08-16
IS5266A (is)	1999-11-23
AP945A (en)	2001-02-28
SK282914B6 (sk)	2003-01-09
KR100371730B1 (ko)	2003-02-07
TR199903282T2 (xx)	2000-08-21
ATE256457T1 (de)	2004-01-15
CA2290973C (en)	2003-06-17
DK0980241T3 (da)	2004-04-05
KR20010013588A (ko)	2001-02-26
HUP0002250A2 (hu)	2000-12-28
HRP980378B1 (en)	2001-12-31
MA24586A1 (fr)	1998-12-31
NO996492L (no)	2000-02-29
WO1999001113A1 (en)	1999-01-14
JP2000512316A (ja)	2000-09-19
OA11246A (en)	2002-11-19
NZ501252A (en)	2004-11-26
BR9809712A (pt)	2000-07-11
AP9801279A0 (en)	1998-06-30
NO996492D0 (no)	1999-12-27
TNSN98123A1 (fr)	2005-03-15
AU724635B2 (en)	2000-09-28
AR015916A1 (es)	2001-05-30
CO4940405A1 (es)	2000-07-24
IL133075A0 (en)	2001-03-19
SK180599A3 (en)	2001-01-18
PA8454001A1 (es)	2000-05-24
DE69820608D1 (de)	2004-01-29
CA2290973A1 (en)	1999-01-14
DE69820608T2 (de)	2004-12-23
ID24673A (id)	2000-07-27
GT199800090A (es)	1999-12-21
CN1261792A (zh)	2000-08-02
DZ2544A1 (fr)	2003-02-08
EA199900963A1 (ru)	2000-08-28
TW382597B (en)	2000-02-21
BG103917A (bg)	2000-07-31
PE97299A1 (es)	1999-10-13
ZA985709B (en)	2000-01-10
PL337807A1 (en)	2000-09-11
MY119728A (en)	2005-07-29
HRP980378A2 (en)	1999-04-30
UY25070A1 (es)	2000-12-29
AU7545098A (en)	1999-01-25
HUP0002250A3 (en)	2001-01-29
ES2210760T3 (es)	2004-07-01
EP0980241A1 (en)	2000-02-23
EA001905B1 (ru)	2001-10-22

Publication	Publication Date	Title
IS5425A (is)	2000-03-31	Læknislyf
DE69928085D1 (de)	2005-12-08	Dosierungsform mit verlängerter wirkstoffabgabe
DE69834019D1 (de)	2006-05-18	Dose
EE04293B1 (et)	2004-06-15	Stabiilsed lüofiliseeritud ravimvormid
DE69930866D1 (de)	2006-05-24	Dosiervorrichtung
DE69818280D1 (de)	2003-10-23	Homogenisierventil
NO972963D0 (no)	1997-06-25	Flerfaset mykgelatindoseringsform
DK1017392T3 (da)	2002-10-21	Lægemiddel
DE69805844D1 (de)	2002-07-11	Ifnnar/ifn komplex
DE69919490D1 (de)	2004-09-23	Puder mit fettlöslichem wirkstoff
BR9507909A (pt)	1997-08-12	Formas de dosagem de rápida dissolução
PT980241E (pt)	2004-03-31	Formas de dosagem encapsuladas em gelatina de sertralina em solucao
NO994619D0 (no)	1999-09-23	Farmasöytiske blandinger
DE69636433D1 (de)	2006-09-21	Halbleiterspeicher mit arithmetikfunktion
ATE228575T1 (de)	2002-12-15	Wirkstoffkombinationen
EA199900672A1 (ru)	2000-02-28	Гомеопатическое лекарственное средство
NO20003141D0 (no)	2000-06-16	Farmasøytiske blandinger
DE59603353D1 (de)	1999-11-18	Dosierstift
DE69811682D1 (de)	2003-04-03	Dosiervorrichtung
EA199900673A1 (ru)	2000-02-28	Гомеопатическое лекарственное средство
DE69709326D1 (de)	2002-01-31	Dosiervorrichtung
ATE238786T1 (de)	2003-05-15	Anti-first-pass-effect-substanzen
FI950737A7 (fi)	1995-08-19	Lääkkeitä
SE9702957D0 (sv)	1997-08-15	Antivirals
FR2760330B1 (fr)	1999-05-07	Jeton composite